Review and consensus on pharmacogenomic testing in psychiatry

CA Bousman, SA Bengesser, KJ Aitchison… - …, 2021 - thieme-connect.com
The implementation of pharmacogenomic (PGx) testing in psychiatry remains modest, in part
due to divergent perceptions of the quality and completeness of the evidence base and …

A review of opioid addiction genetics

RC Crist, BC Reiner, WH Berrettini - Current opinion in psychology, 2019 - Elsevier
Highlights•Opioid use disorder risk has a large heritable component (23–54%).•The OPRM1
variant rs1799971 (aka A118G) as a small effect on risk for OUD and general substance …

Multi-ancestry study of the genetics of problematic alcohol use in over 1 million individuals

H Zhou, RL Kember, JD Deak, H Xu, S Toikumo… - Nature Medicine, 2023 - nature.com
Problematic alcohol use (PAU), a trait that combines alcohol use disorder and alcohol-
related problems assessed with a questionnaire, is a leading cause of death and morbidity …

Association of OPRM1 functional coding variant with opioid use disorder: a genome-wide association study

H Zhou, CT Rentsch, Z Cheng, RL Kember… - JAMA …, 2020 - jamanetwork.com
Importance With the current opioid crisis, it is important to improve understanding of the
biological mechanisms of opioid use disorder (OUD). Objectives To detect genetic risk …

Human genetics of addiction: new insights and future directions

DB Hancock, CA Markunas, LJ Bierut… - Current psychiatry …, 2018 - Springer
Abstract Purpose of Review With the advent of the genome-wide association study (GWAS),
our understanding of the genetics of addiction has made significant strides forward. Here …

Molecular genetics of substance use disorders: An umbrella review

S Lopez-Leon, Y Gonzalez-Giraldo… - Neuroscience & …, 2021 - Elsevier
Background Substance use disorders (SUD) are a category of psychiatric disorders with a
large epidemiological and societal impact around the world. In the last decades, a large …

Multi-trait genome-wide association study of opioid addiction: OPRM1 and beyond

N Gaddis, R Mathur, J Marks, L Zhou, B Quach… - Scientific reports, 2022 - nature.com
Opioid addiction (OA) is moderately heritable, yet only rs1799971, the A118G variant in
OPRM1, has been identified as a genome-wide significant association with OA and …

Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1

AH Smith, KP Jensen, J Li, Y Nunez, LA Farrer… - Molecular …, 2017 - nature.com
Opioids are very effective analgesics, but they are also highly addictive. Methadone is used
to treat opioid dependence (OD), acting as a selective agonist at the μ-opioid receptor …

A brief review of the genetics and pharmacogenetics of opioid use disorders

W Berrettini - Dialogues in clinical neuroscience, 2017 - Taylor & Francis
Increased physician prescribing of opioids to treat chronic nonprogressive pain has been
accompanied by an increase in opioid addiction. Twin studies of opioid addiction are …

OPRM1 A118G Polymorphisms and Its Role in Opioid Addiction: Implication on Severity and Treatment Approaches

MM Taqi, M Faisal, H Zaman - … and personalized medicine, 2019 - Taylor & Francis
The epidemic of opioid addiction is shaping up as the most serious clinical issues of current
times. Opioids have the greatest propensity to develop addiction after first exposure …